Vimarsana
Biggest News Aggregation in the World

Page 4 - Bun P News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bun P. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bun P Today - Breaking & Trending Today

Wall Street drops as job gains fuel rate-hike worries - Vimarsana News

Wall Street drops as job gains fuel rate-hike worries

The Nasdaq led losses among Wall Street's main indexes on Monday, with technology stocks taking a hit on concerns that the Federal Reserve will continue to hike interest rates after Friday's jobs data indicated a resilient labor market.

SNAPSHOT S&P 500, Nasdaq rise as economic data eases rate hike worries - Vimarsana News

SNAPSHOT S&P 500, Nasdaq rise as economic data eases rate hike worries

Investor bets shifted in favor of a pause in the Federal Reserve's interest rate hikes in May.

Wall St falls as bank contagion fears flare up - Vimarsana News

Wall St falls as bank contagion fears flare up

Wall Street's main indexes fell on Friday as investors fled from risky assets on growing concerns that a contagion in the banking sector had not been fully confined despite assurances from key officials.

Innovent Releases Results of High-dose Cohorts in Phase 1 Clinical Study of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity at ENDO 2022 - Vimarsana News

Innovent Releases Results of High-dose Cohorts in Phase 1 Clinical Study of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity at ENDO 2022

SAN FRANCISCO and SUZHOU, China, June 13, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the results of high-dose cohorts in a phase 1 clinical trial of mazdutide (IBI362), a glucagon-like petide-1 (GLP-1) and glucagon receptor dual agonist, in Chinese adults with overweight or obesity are presented as an on-demand poster (ODP014) at ENDO 202...

Do business and ethics go hand in hand? - Vimarsana News

Do business and ethics go hand in hand?

Do business and ethics go hand in hand? - Real Business is the content brand that tells the truth about SME life today.